rs2272252

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000083.3(CLCN1):​c.1402-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.412 in 1,578,338 control chromosomes in the GnomAD database, including 136,568 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.44 ( 15197 hom., cov: 32)
Exomes 𝑓: 0.41 ( 121371 hom. )

Consequence

CLCN1
NM_000083.3 intron

Scores

2
Splicing: ADA: 0.00001508
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.584

Publications

11 publications found
Variant links:
Genes affected
CLCN1 (HGNC:2019): (chloride voltage-gated channel 1) The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence homology. The protein encoded by this gene regulates the electric excitability of the skeletal muscle membrane. Mutations in this gene cause two forms of inherited human muscle disorders: recessive generalized myotonia congenita (Becker) and dominant myotonia (Thomsen). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
CLCN1 Gene-Disease associations (from GenCC):
  • myotonia congenita, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • myotonia congenita, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Thomsen and Becker disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-143339244-C-T is Benign according to our data. Variant chr7-143339244-C-T is described in ClinVar as Benign. ClinVar VariationId is 359111.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.554 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000083.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN1
NM_000083.3
MANE Select
c.1402-9C>T
intron
N/ANP_000074.3
CLCN1
NR_046453.2
n.1357-9C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCN1
ENST00000343257.7
TSL:1 MANE Select
c.1402-9C>T
intron
N/AENSP00000339867.2
CLCN1
ENST00000432192.6
TSL:1
n.*687-9C>T
intron
N/AENSP00000395949.2
CLCN1
ENST00000650516.2
c.1402-9C>T
intron
N/AENSP00000498052.2

Frequencies

GnomAD3 genomes
AF:
0.438
AC:
66598
AN:
151958
Hom.:
15163
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.560
Gnomad AMI
AF:
0.206
Gnomad AMR
AF:
0.338
Gnomad ASJ
AF:
0.513
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.405
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.484
Gnomad NFE
AF:
0.411
Gnomad OTH
AF:
0.450
GnomAD2 exomes
AF:
0.401
AC:
100807
AN:
251474
AF XY:
0.402
show subpopulations
Gnomad AFR exome
AF:
0.571
Gnomad AMR exome
AF:
0.304
Gnomad ASJ exome
AF:
0.505
Gnomad EAS exome
AF:
0.259
Gnomad FIN exome
AF:
0.382
Gnomad NFE exome
AF:
0.418
Gnomad OTH exome
AF:
0.422
GnomAD4 exome
AF:
0.409
AC:
583403
AN:
1426262
Hom.:
121371
Cov.:
29
AF XY:
0.410
AC XY:
291601
AN XY:
711868
show subpopulations
African (AFR)
AF:
0.561
AC:
18252
AN:
32546
American (AMR)
AF:
0.310
AC:
13854
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
12943
AN:
25862
East Asian (EAS)
AF:
0.304
AC:
12007
AN:
39554
South Asian (SAS)
AF:
0.417
AC:
35602
AN:
85466
European-Finnish (FIN)
AF:
0.387
AC:
20671
AN:
53378
Middle Eastern (MID)
AF:
0.450
AC:
2571
AN:
5708
European-Non Finnish (NFE)
AF:
0.410
AC:
442357
AN:
1079804
Other (OTH)
AF:
0.424
AC:
25146
AN:
59256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
17580
35160
52740
70320
87900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13404
26808
40212
53616
67020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.439
AC:
66688
AN:
152076
Hom.:
15197
Cov.:
32
AF XY:
0.433
AC XY:
32174
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.560
AC:
23238
AN:
41484
American (AMR)
AF:
0.338
AC:
5160
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.513
AC:
1780
AN:
3472
East Asian (EAS)
AF:
0.271
AC:
1401
AN:
5178
South Asian (SAS)
AF:
0.406
AC:
1959
AN:
4820
European-Finnish (FIN)
AF:
0.373
AC:
3935
AN:
10554
Middle Eastern (MID)
AF:
0.480
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
0.411
AC:
27944
AN:
67968
Other (OTH)
AF:
0.447
AC:
942
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1903
3805
5708
7610
9513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.430
Hom.:
10060
Bravo
AF:
0.441
Asia WGS
AF:
0.352
AC:
1230
AN:
3478
EpiCase
AF:
0.424
EpiControl
AF:
0.426

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 28, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 22, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 25, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Batten-Turner congenital myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Congenital myotonia, autosomal recessive form;C2936781:Congenital myotonia, autosomal dominant form Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myotonia, autosomal dominant form Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Congenital myotonia, autosomal recessive form Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.2
DANN
Benign
0.44
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000015
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2272252; hg19: chr7-143036337; COSMIC: COSV58371810; API